Is this you? Create Your Porfile
Avatar

Kathryn A. Hanley

Office of Technology Transfer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Kathryn A. Hanley is active.

Explore More

Publication

Featured researches published by Kathryn A. Hanley.

Archive | 2003

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

Stephen S. Whitehead; Brian R. Murphy; Lewis Markoff; Barry Falgout; Joseph E. Blaney; Kathryn A. Hanley

Archive | 2006

Attenuated dengue virus comprising mutations in the NS3 gene

Stephen S. Whitehead; Brian R. Murphy; Kathryn A. Hanley; Joseph E. Blaney

Archive | 2014

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3' untranslated region

Stephen S. Whitehead; Brian R. Murphy; Kathryn A. Hanley; Joseph E. Blaney; Ching-Juh Lai

Archive | 2009

Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

Stephen S. Whitehead; Brian R. Murphy; Kathryn A. Hanley; Joseph E. Blaney

Archive | 2013

Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

Stephen S. Whitehead; Brian R. Murphy; Kathryn A. Hanley; Joseph E. Blaney; Ching-Juh Lai

Archive | 2013

Short Communication Replacement of conserved or variable sequences of the mosquito-borne dengue virus 39 UTR with homologous sequences from Modoc virus does not change infectivity for mosquitoes

Ebenezer Tumban; Nyree E. Maes; Erin E. Schirtzinger; Katherine I. Young; Christopher T. Hanson; Stephen S. Whitehead; Kathryn A. Hanley

Archive | 2011

Short Communication Replacement of the 39 untranslated variable region of mosquito-borne dengue virus with that of tick- borne Langat virus does not alter vector specificity

Ebenezer Tumban; Dana N. Mitzel; Nyree E. Maes; Stephen S. Whitehead; Kathryn A. Hanley

Archive | 2010

Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2.

Stephen S. Whitehead; Brian R. Murphy; Lewis Markoff; Barry Falgout; Joseph E. Blaney; Kathryn A. Hanley

Archive | 2003

Dengue-vakzine mit einer gemeinsamen 30 nukleotid-deletion im 3'-utr der dengue-typen 1 und 2. Dengue vaccine containing a common 30 nucleotide deletion in the 3 'UTR of Dengue types 1 and 2. FIG.

Stephen S. Whitehead; Brian R. Murphy; Lewis Markoff; Barry Falgout; Joseph E. Blaney; Kathryn A. Hanley

Archive | 2003

Dengue-vakzine mit einer gemeinsamen 30 nukleotid-deletion im 3'-utr der dengue-typen 1 und 2.

Stephen S. Whitehead; Brian R. Murphy; Lewis Markoff; Barry Falgout; Joseph E. Blaney; Kathryn A. Hanley

Explore More

Collaboration

Dive into the Kathryn A. Hanley's collaboration.

Top Co-Authors
Avatar

Stephen S. Whitehead

Johns Hopkins University

View shared research outputs
Top Co-Authors
Avatar

Brian R. Murphy

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Joseph E. Blaney

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Barry Falgout

Food and Drug Administration

View shared research outputs
Top Co-Authors
Avatar

Lewis Markoff

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Ching-Juh Lai

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Ebenezer Tumban

University of New Mexico

View shared research outputs
Top Co-Authors
Avatar

Nyree E. Maes

New Mexico State University

View shared research outputs
Top Co-Authors
Avatar

Christopher T. Hanson

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Dana N. Mitzel

National Institutes of Health

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge